Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03388008 · ClinicalTrials.gov registry record · Phase 2
Belatacept Pilot Study in Lung Transplantation Immunosuppression in Lung Transplantation
A Phase 2 study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- Phase 2
- Development phase
- 27
- Enrollment target
NCT03388008 is a Phase 2 study that has completed, run by Washington University School of Medicine. The registered enrollment target is 27 participants.
The verdict
NCT03388008, a Phase 2 study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 27 participants
- Enrollment target
Study Summary
This is a pilot randomized controlled trial examining the feasibility of conducting a large scale randomized controlled trial of belatacept-based immunosuppression in lung transplantation. This pilot study will enroll 40 lung transplant recipients and randomize them to belatacept-based immunosuppression or standard of care. The primary endpoint of the study is the development of donor-specific HLA antibodies after transplantation. All study participants will be followed for a minimum of 12 months after transplantation.
Interventions
- DRUG Mycophenolate Mofetil
- DRUG Methylprednisolone
- DRUG Tacrolimus
- DRUG ATG
- DRUG Belatacept
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2019-12-17 |
| Est. Completion | 2022-08-31 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03388008
The ClinicalTrials.gov registry entry for NCT03388008 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Mycophenolate Mofetil is the first listed.
NCT03388008 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03388008 about?
NCT03388008 is a clinical study titled "Belatacept Pilot Study in Lung Transplantation Immunosuppression in Lung Transplantation". This is a pilot randomized controlled trial examining the feasibility of conducting a large scale randomized controlled trial of belatacept-based immunosuppression in lung transplantation. This pilot study will enroll 40 lung transplant recipients and randomize them to belatacept-based immunosuppres...
What is the current status of trial NCT03388008?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 27 participants. The study started on 2019-12-17. Estimated completion is 2022-08-31.
What interventions are being tested in trial NCT03388008?
The interventions under investigation include: Mycophenolate Mofetil (DRUG), Methylprednisolone (DRUG), Tacrolimus (DRUG), ATG (DRUG), Belatacept (DRUG).
Who is sponsoring clinical trial NCT03388008?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.